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Abstract
Several reports link cigarette smoking with leukemia. However, the effects of cigarette smoke extract (CSE) on bone marrow
hematopoiesis remain unknown. The objective of this study was to elucidate the direct effects of cigarette smoke on human
bone marrow hematopoiesis and characterize the inflammatory process known to result from cigarette smoking. Bone
marrow mononuclear cells (BMCs) from healthy individuals when exposed to CSE had significantly diminished CFU-E, BFU-E
and CFU-GM. We found increased nuclear translocation of the NF-kB p65 subunit and, independently, enhanced activation
of AKT and ERK1/2. Exposure of BMCs to CSE induced IL-8 and TGF-b1 production, which was dependent on NF-kB and
ERK1/2, but not on AKT. CSE treatment had no effect on the release of TNF-a, IL-10, or VEGF. Finally, CSE also had a
significant induction of TLR2, TLR3 and TLR4, out of which, the up-regulation of TLR2 and TLR3 was found to be dependent
on ERK1/2 and NF-kB activation, but not AKT. These results indicate that CSE profoundly inhibits the growth of erythroid
and granulocyte-macrophage progenitors in the bone marrow. Further, CSE modulates NF-kB- and ERK1/2-dependent
responses, suggesting that cigarette smoking may impair bone marrow hematopoiesis in vivo as well as induce
inflammation, two processes that proceed malignant transformation.
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Introduction
Cigarette smoking is a substantial contributor to the pathogen-
esis of many diseases, including cancer, predisposition to infections
as well as a contributing factor to the failure of therapeutic
modalities, such as HSCT transplants [1,2,3,4,5]. Numerous
studies have suggested a strong link between exposure to cigarette
smoke (CS) and an increase in the risk of developing myeloid
leukemia in adults, as well as the association between parental
smoking and childhood lymphomas and leukemias [6,7]. Tobacco
use may result in an imbalance of the hematopoietic system, such
as changes in the erythrocyte-leukocyte ratio and the composition
of mature leukocytes in the peripheral blood [8]. Furthermore,
recent studies have demonstrated the ability of bone marrow-
derived stem cells to respond to induced epithelial repair and are
also linked with cigarette smoke-induced lung cancer [9].
Interestingly, apart from these observations, the mechanisms by
which smoking impairs the hematopoietic system are not well
understood.
It has been reported that cigarette smoke-induced inflammation
and impairment in humans is associated with bone marrow
stimulation and an accelerated release of leukocytes into the
circulation [10]. However, while some of the mechanisms by
which cigarette smoke and CSE causes functional impairment
have been studied in PBMC and non-immune cells, the direct
behavior of such pathways in primary bone marrow cells remain
poorly understood [11].
Toll-like receptors (TLRs) are key innate immune receptors
involved in initiating the recognition of pathogens by the immune
system and in facilitating the myeloid replenishment/recruitment
by HSCs in response to inflammation [12,13,14]. Previous studies
have shown that CSE can up-regulate the expression of TLR4 on
human macrophages, neutrophils, and bronchial epithelial cells;
TLR2 in CS–exposed mice, smokers and patients with COPD;
and TLR3 in adenocarcinoma cells [12,15,16,17]. The activation
of TLRs promotes the activation of signaling pathways, such as
phospho inositol-3 kinase (PI3K)/AKT, nuclear factor-kB (NF-
kB) and extracellular signal-regulated kinase 1/2 (ERK1/2),
which lead to the production of pro-inflammatory cytokines and
chemokines important for immune responses [15,18,19]. Among
these, NF-kB has been reported to play an important role in
mediating cell survival and the up-regulation of many cytokines
and pro-inflammatory mediators essential to the host, and ERK1/
2 has been reported to mediate transcription of proteases and
cytokines in response to a variety of stimuli, including CS [20].
Furthermore, a number of studies have demonstrated that NF-kB
and MAPK signaling pathways become activated in response to
CS [21,22]. Therefore, several signaling pathways may be
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cigarette smoke-induced immunosuppressive properties.
In this study, the impact of CSE on bone marrow hematopoi-
esis, expression and signaling of TLR2, TLR3, and TLR4 in bone
marrow mononuclear cells (BMCs) from healthy volunteers was
investigated.
Results
Cigarette Smoke Extract Reduced the Colony Formation
of BMCs
Examination of colony formation following exposure to various
agents is a sensitive indicator of toxicity and as mentioned earlier,
human BM-derived progenitors might be the most applicable to
the toxicology of human CS exposure [23]. Therefore, our
primary goal was to determine the effects of CSE on BM
hematopoiesis. We did this by studying a number of different types
of progenitor cell colonies formed (BFU-E, CFU-E and CFU-GM)
by BMCs after exposure to different concentrations of CSE. BMCs
exposed to CSE had a profound decrease in the numbers of CFU-
U, BFU-E, and CFU-GM scores when compared to control
treated cells (media alone). Even the lowest concentration (5%
CSE) showed a significant inhibitory effect on the growth of
erythroid progenitors (CFU-E and BFU-E) and granulocyte-
macrophage progenitors (CFU-GM) (Fig. 1), demonstrating that
progenitor cells are highly sensitive to the hematotoxic effects of
CSE.
Cigarette Smoke Extract Induces Nuclear Translocation of
NF-kB and Activation of PI3K/AKT and ERK1/2 in BMCs
NF-kB belongs to a family of transcription factors that regulates
many cellular processes such as inflammation, immune activation,
cell proliferation, and apoptosis [24,25]. In most cells, NF-kB
factors are stored in an inactive state in the cytoplasm until
activating signals induce nuclear translocation [24,26,27]. Impor-
tantly, this factor has been previously shown to be activated in
response to CSE exposure. Therefore, we aimed to determine
whether exposure of BMCs to CSE could also result in activation
of NF-kB. We treated BMCs with different concentrations of CSE
for 24 hours and immunoblotted the cytoplasmic and nuclear
portions for the NF-kB subunit, p65. We observed that CSE
induced nuclear translocation of p65 in a dose-dependent manner
(Fig. 2A). To investigate whether CSE could stimulate the
activation of other pathways, BMCs were treated with 5% or
10% CSE for 6 h and CSE-mediated activation of AKT and ERK
was then determined by Western Blot analysis looking at the
phosphorylation status of AKT and ERK. As shown in figure 2B,
we also see increased activation in response to CSE.
IkBa Phosphorylation by CSE Is Independent of the
Activation of PI3K/AKT and ERK1/2 in BMCs
The PI3K/AKT signaling pathway has been shown to activate
NF-kB [28,29]. As shown above, CSE can activate PI3K/AKT
signaling, therefore, we reasoned that this pathway might also be
responsible for activating NF-kB in BMCs. To test this, BMCs
were pretreated with Wortmannin (PI3K inhibitor) and then
stimulated with CSE. In an unactivate state, NF-kB is sequestered
in the cytoplasm by the action of an inhibitory protein IkBa, Upon
cellular activation, IkBa becomes phosphorylated and subsequent-
ly degraded, and NF-kB is released and free to translocate into the
nucleus where it can then regulate the transcription its target
genes. [30]. Therefore we tested if there was a link between the
phosphorylation of IkBa and the PI3K pathway in CSE-induced
activation of NF-kB. We examine IkBa phosphorylation after
treatment with CSE, with and without inhibition of PI3K. We
found that while CSE-mediated phosphorylation of AKT was
effectively ablated by PI3K inhibition, CSE-induced IkBa
phosphorylation in BMCs was not (Fig.3). These data demonstrate
that PI3K/AKT signaling does not lie upstream of NF-kB in CSE-
pathogenesis and is not responsible for the CSE-induced NF-kB
activity seen in BMCs.
We showed earlier that MAPK in BMCs (represented by
ERK1/2) was also hyperactive in response to CSE and numerous
reports have shown that CSE can activate the MAPK signaling
pathway [20,21,22]. Therefore, we assessed the impact of ERK
activation on CSE-induced NF-kB activation in BMCs. Cells were
pretreated with 10 mM of the MAPK inhibitor, PD098059, for 1 h
and then stimulated with CSE for 6 h, as we did for PI3K with
Wortmaninn. We were able to block CSE-mediated ERK1/2
activation using PD098059, but there was no significant change in
CSE-induced IkBa phosphorylation, indicating that CSE has a
direct effect on NF-kB activation in BMCs.
CSE Induces TLR Expression on BMCs
TLR4 has been implicated in the activation of AKT and
MAPK and activating signals emanating from TLRs are well
known to induce activation of NF-kB in antigen-presenting cells,
which results in the production of several pro-inflammatory
cytokines [31,32]. To explore whether CSE is able to affect the
expression of TLRs, BMCs were stimulated with 10% CSE, and
then evaluated for their expression of TLR2, TLR3, and TLR4.
We found that BMCs exposed to 10% CSE not only increased
intracellular expression of TLR2, TLR3, and TLR4 (Fig 4B), but
we also saw a dramatic increase in the surface expression of these
TLRs (Fig 4C). Up to this point we have demonstrated that CSE
seems to target the direct activation of NF-kB and hence we
wanted to understand if the activation is linked to the up-
regulation of TLRs. Pretreatment of BMCs with the NF-kB
Figure 1. Effects of CSE on the clonal growth of normal human
CFU-GM, BFU-E and CFU-E in BMCs. Bone marrow mononuclear
cells from healthy volunteers were treated with different concentrations
of CSE for 24 h, then the BMCs were harvested and grown in
methylcellulose medium with cytokines as described in Materials and
methods. At the end of the 24 h, the number of colonies per well was
determined. Each point represents the mean results of three normal
individuals, and each experimental point represents duplicate plates.
Results are expressed as mean value 6 SD (* P,0.001).
doi:10.1371/journal.pone.0021173.g001
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sion of TLR2 and TLR3, as well as surface expression of TLR2
(Fig 4B, C), demonstrating that CSE-induced NF-kB activation is
responsible for the up-regulation of these specific TLRs. Further,
ERK1/2 inhibition also leads to decreased intracellular expression
of TLR2, although to a lesser extent. However, PI3K/AKT
inhibition with wortmannin had no effect on TLR expression
suggesting that this last pathway is not directly involved in the
regulation of TLR expression after CSE exposure. Thus, exposing
BMCs to CSE results in increased TLR expression with the
expression of TLR2 and TLR3 being at least partially mediated
through activation of ERK1/2 and NF-kB.
CSE Has No Effect on TNF-a, VEGF and IL-10 Production
by BMCs
Proliferation, differentiation, and self-renewal of bone marrow
hematopoietic cells are in part mediated by soluble factors,
including cytokines and chemokines [8]. However, the result of
cigarette smoke exposure on the production and release of
inflammatory mediators remains unclear. In the present study
we investigated whether Tumor necrosis factor-a (TNF-a),
vascular endothelial growth factor (VEGF) and, interleukin-10
(IL-10) production by BMCs is modulated by CSE. BMCs were
incubated with control medium, 5% CSE, 10% CSE or 1 mg/ml
of LPS for 24 h, and then the supernatants were collected and the
release of TNF- a (Fig. 5A), IL-10 (Fig 5B) and VEGF (Fig. 5C)
was measured by ELISA. We found that CSE did not induce the
production of TNF-a, IL-10, or VEGF in BMCs.
Effects of CSE on IL-8 Release
The activation of NF-kB, ERK and AKT pathways induces the
expression of pro-inflammatory mediators, such as interleukin-8
(IL-8) [15,18]. To assess whether CSE affects the release of this
cytokine by BMCs, IL-8 concentrations were measured in the
culture supernatants. Stimulation of BMCs with CSE elicited a
time-dependent increase in IL-8 production. We found that CSE
significantly induced IL-8 release at both doses (5% and 10%)
(Fig. 6A) and three different time points, 1 h, 6 h and 24 h
(Fig. 6B–D). PD98059 and BAY11-7085, but not Wortmannin,
reduced the release of IL-8 by CSE-stimulated BMCs. Taken
Figure 2. Cigarette smoke extract (CSE) induced the activation of NF-kB, AKT and ERK1/2 in BMCs. (A) BMCs were incubated with media,
5% CSE, 10% CSE, 20% CSE or 1 mg/ml LPS for 24 h, then cells were harvested and the cytoplasmic and nuclear protein fractions were separated using
Pierce Nuclear and Cytoplasmic Extraction Reagent Kit (NE-PER). 30 mg of each, cytoplasmic and nuclear extracts, was analyzed by 10% SDS-PAGE and
Western blotted using NF-kB p65 antibody. For loading control of cytoplasmic protein, the membrane was stripped and immunoblotted for b-actin
antibody; for loading control of nuclear protein, the membrane was blotted with anti-PARP antibody. Three independent experiments were done, but
one representative experiment is shown. (B) BMCs from donor 1 and donor 2 were incubated with control media, 5% CSE or 10% CSE for 6 h at which
point cells were harvested and lysed. Cell lysates were separated by SDS-PAGE and immunoblotted with an anti-p-ERK antibody or anti-p-AKT
(ser473) antibody, and the membranes were subsequently stripped and reprobed with anti-ERK, anti-AKT or b-actin antibodies.
doi:10.1371/journal.pone.0021173.g002
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involved in CSE-mediated IL-8 secretion, whereas AKT is not.
Effects of CSE on TGF-b1 Release
A large number of in vitro studies have shown that transforming
growth factor-b (TGF-b1) plays a critical role in the regulation of
hematopoiesis, in particular as a growth inhibitor of progenitor
and stem cells [33]. It was found that 10% CSE induced the
release of TGF-b1 by BMCs (Fig.7A). Similar to our IL-8 data,
inhibition of MAPKs and NF-kB but not PI3K/AKT inhibition
prevented the release of TGF-b1, indicating that ERK1/2 and
NF-kB are involved in the TGF-b1 release, whereas AKT is not
(Fig 7B).
Discussion
Erythropoiesis and granulopoiesis are multistep processes that
involve the differentiation of hemopoietic stem cells into the
precursors of mature erythrocytes (BFU-E, CFU-E, erythroid
precursors) and monocytes/granulocytes (CFU-GM) respectively
[34–35]. While these pathways are critical in the development of
leukemias and blood cancers, the changes in their phenotype and
functionality after direct interaction with CS has not been
elucidated. In this study, we examined the effects of CSE on
normal human granulocyte-macrophage (CFU-GM) and ery-
throid (CFU-E, BFU-E) cells. We report that the colony forming
ability of these progenitors is highly sensitive to CSE and are
affected even at very low doses. In particular, we discovered that
the capacity of human BMCs to form BFU-E, CFU-E, and CFU-
GM is impaired after treatment with CSE, indicating an in vitro
ability to inhibit hematopoiesis. This exposure correlated with a
significant increase in the expression of the innate immune
receptors: TLR2, TLR3 and TLR4, partly mediated through the
activation of the ERK1/2 and NF-kB signaling cascades, but not
AKT (Figure 8). In addition, our data revealed that CSE
modulates the cytokine response of human BMCs by inducing
the release of suppressive, tumor differentiating cytokines such as
TGF-b1 and IL-8 (normally over-expressed in advanced cancer
[36], but not others such as the pro-apoptotic TNF-a, the anti-
inflammatory IL-10, or the angiogenic VEGF. The effects
observed with our studies suggest that CSE-induced activation of
ERK1/2 and NF-kB signaling cascades in BMCs may be a main
contributor to abnormal immune responses linked to the
pathogenesis of CS. This provides the mechanistic basis to
understand the link between cigarette smoking and the deregu-
lation of the bone marrow microenvironment which could lead to
leukemia.
TLRs play a key role in pathogen recognition and regulation of
immune responses and more recently have become notorious due
to their role on the regulation of the tumor microenvironment
[37]. This has linked them to chemo-resistance and tumorigenesis
processes [38]. However, despite many years of research,
mechanisms governing TLR expression as well as their regulation
by specific tumorigenic insults remain largely unknown. In this
study, we found that exposure of BMCs to 10% CSE increased
both the intracellular and extracellular expression of TLR2,
TLR3, and TLR4. However, this finding is not surprising due to
the known inflammatory nature of CSE. Again, while not
completely unexpected, this upregulation of TLRs provide a
previously uncharacterized leaving link between leukemias and
CSE. Our next step was to try to understand how this up-
regulation is induced.
Three main pathways are involved in TLR up-regulation:
PI3K/AKT pathway is thought to participate in the TLR2- and
TLR4-signaling pathways and can act as either positive or a
negative regulators of those cascades; NF-kB signaling has also
been implicated in the expression of TLR2 induced by various
stimuli, and MAPKs have also been linked to the expression of
TLRs by various stimuli [39,40,41,42]. To test the specific role of
each one of those pathways we relied on established inhibitors to
better understand their role in the induction or TLRs after CSE
exposure. Wortmannin is a highly specific and potent inhibitor of
PI3K. At nanomolar concentrations this inhibitor irreversibly and
fully inhibits PI 3-kinase with very little effect on other signaling
molecules (one of the main reasons we chose it in our studies).
BAY 11-7085 is an irreversible inhibitor of NF-kB which at higher
concentrations can also activate JNK and p38 MAPK, inhibit cell
proliferation, and induce apoptosis. PD98059 is a highly selective
cell permeable inhibitor of MAP kinase kinase (MEK); it is a
noncompetitive inhibitor that affects MEK substrates ATP and
ERK. Because CSE is known to activate PI3K/AKT signaling we
reasoned that this pathway could be playing a role in the up-
regulation of TLRs by BMCs. Instead we found that PI3K/AKT
inhibition had no effect on TLR expression but that inhibiting NF-
kB effectively suppresses intracellular expression of TLR2 and
TLR3 as well as the expression of TLR2 on the surface of the cells,
showing that NF-kB is in part responsible for CSE-induced TLR2
and TLR3 expression on BMCs. This pathway has been shown to
play a critical role in regulating the inflammatory response by
myeloid cells and is known to be potently activated by CS [43,44].
At the same time, we found that inhibition of NF-kB did not block
activation of AKT and ERK1/2 induced by CSE in BMCs. Taken
together, CSE activates AKT, ERK1/2 and NF-kB via distinct,
non-overlapping mechanisms. Complementing the effects of NF-
kB inhibition was ERK which also attenuated intracellular
Figure 3. CSE-induced NF-kB activation is independent of the
activation of PI3K/AKT and ERK1/2 in BMCs. BMCs were
pretreated with PD98059 (10 mM), BAY11-7085 (5 mM), or Wortmannin
(100 nM) for 60 min, and were subsequently exposed to 10% CSE for
6 h then cells were harvested and lysed. Cell lysates were separated by
SDS-PAGE and immunoblotted with an anti-p-ERK antibody, anti-p-AKT
(Ser473) or anti-p-IkBa (Ser32) antibody. The membranes were then
stripped and reprobed with anti-ERK, anti-AKT or b-actin antibodies.
doi:10.1371/journal.pone.0021173.g003
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activated after exposure of BMC to CSE. Based on the fact that
the same exposure induced TGF-b and IL-8 it could be reasoned
that activation of ERK and NF-kB may be through the release of
these cytokines, which are known to activate these two particular
pathways [45]. In addition, hyperactive NF-kB and MAPK
pathways have been implicated in tumorigenesis and contribute to
the malignant growth of multiple myeloma (MM) [46]. Therefore,
our findings here that the activation of these two pathways by CSE
furthers the idea that direct exposure to CSE (likely by absorption
through the blood during inhalation) can have a profound effect
on progenitor cells and the development of abnormal hemato-
poeisis.
The validity of our system relies on the use of an already
established model for the study of cigarette smoke exposure in
vitro. Therefore, while this system cannot fully replicate the
complex in vivo effects of long-term cigarette smoking, it provides
a unique tool to understand the activation of specific pathways
after exposure. Furthermore, our study was performed on human
primary bone marrow cells, which provide a unique window into
how these pathways might also be affected in the population and
provides a basis for translational studies. Our future studies will
Figure 5. CSE had no effect on IL-10, TNF-a, and VEGF production. BMCs were incubated with media, 5% CSE, 10% CSE or 1 mg/ml LPS for
24 h, and the supernants were harvested and analyzed for the presence of IL-10, TNF-a and VEGF by ELISA. Results are expressed as mean value 6 SD
of five different normal donors. (* P,0.001).
doi:10.1371/journal.pone.0021173.g005
Figure 4. CSE-induced TLR2 and TLR3 expression in BMCs may be in part mediated through activation of ERK1/2 and NF-kB
signaling cascades. BMCs were pretreated with PD98059 (10 mM), BAY11-7085 (5 mM), or Wortmannin (100 nM) for 60 min, and then exposed to
10% CSE for 24 h, after which the cells were harvested and used for flow cytometric analysis. (A) BMCs were gated according to forward scatter (FSC)
and side scatter (SSC) profiles. For cell surface staining, 7-AAD negative cells (live cells) were gated for TLRs expression analysis. Histograms show
representative fluorescence intensities of TLRs; BMCs were labeled with anti-TLR2-PE, anti-TLR3-PE or anti-TLR4-APC antibodies (blue line histogram)
or appropriate isotype control antibodies (red line histogram). (B) For intracellular TLR2, TLR3 or TLR4 staining, cells were washed and then fixed and
permeabilized. (C) For cell surface expression of TLR2, TLR3 or TLR4, the cells were incubated with anti-TLR2-PE, anti-TLR3-PE or anti-TLR4-APC
antibodies for 30 min in the dark on ice, washed and resuspended in PBS. The experiment is a representation of three independent experiments.
doi:10.1371/journal.pone.0021173.g004
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data we have obtained in this study and to better understand the
role the bone marrow microenvironment plays on CSE induced
toxicities by either acting as a buffer or an accelerant of the
tumorigenic process. In summary, we provide the first evidence
that CSE affects human bone marrow hematopoiesis and provide
new insights into the molecular mechanisms underlying the
pathogenesis of bone marrow-related inflammation and cancers
in smokers. Moreover, it is plausible that up-regulation of TLRs
and activation of inflammatory signaling and production of
cytokines by CSE contributes to disease pathogenesis and provides
the basis for the use of inhibitors of TLR2, TLR3, ERK1/2 and
NF-kB to diminish CS-induced human hematoxic effects as a
preventative measure against cancer for long term smokers and
their families.
Materials and Methods
General Reagents
Rabbit Abs to NF-kB p65, phospho-ERK1/2 (Thr202/
Tyr204), phospho-AKT (Ser473), phosphor-IkBa (Ser32), ERK,
AKT, PARP, horseradish peroxidase-conjugated anti-rabbit IgG
and horseradish peroxidase-conjugated anti-mouse IgG were
purchased from Cell Signaling Technology. Mouse anti-b-actin
was purchased from Sigma. PD98059, BAY11-7085 and Wort-
mannin were purchased from Calbiochem (La Jolla, CA). Bone
marrow from healthy volunteers was purchased from Cambrex
(Gaithersburg, MD), and BMCs were isolated from healthy donors
by Ficoll-Hypaque gradient centrifugation. BMCs were main-
tained in RPMI 1640 supplemented with 10% FBS and 100 U/ml
penicillin/streptomycin (control medium).
Figure 6. Effects of ERK1/2, AKT and NF-kB signaling pathway on CSE-induced IL-8 release. A, BMCs were incubated with media, 5% CSE,
10% CSE, or 1 mg/ml LPS for 24 h, and cell supernatants were tested for IL-8. B, BMCs were pretreated with PD98059 (10 mM), BAY11-7085 (5 mM), or
Wortmannin (100 nM) for 60 min, and subsequently were exposed to 10% CSE for 1, 6, and 24 h. The levels of IL-8 were measured in cell supernatant
by ELISA. Data are mean with SEM of five different normal donors. (* P,0.01; ** P,0.001).
doi:10.1371/journal.pone.0021173.g006
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Commercial cigarettes (Marlboro) were smoked continuously by
a smoking apparatus, and the mainstream smoke was drawn
through 30 ml of serum-free RPMI 1640 medium by application
of a vacuum to the vessel containing medium. Each cigarette was
smoked for 5 min, and three cigarettes were used per 30 ml of
serum-free medium, and the suspension was then adjusted to pH
7.4 and filtered through a 0.22-mm pore filter. This solution was
Figure 7. Effects of ERK1/2, AKT and NF-kB signaling pathway on CSE-induced TGF-b1 release. BMCs were pretreated with PD98059
(10 mM), BAY11-7085 (5 mM), or Wortmannin (100 nM) for 60 min, and subsequently were exposed to 10% CSE for 24 h. The levels of TGF-b1 were
measured in cell supernatant by ELISA. Data are mean with SEM of five different normal donors. (* P,0.05; ** P,0.01; *** P,0.001).
doi:10.1371/journal.pone.0021173.g007
Figure 8. Proposed Model for Overall effects of CSE on BMCs. CSE can inhibit the growth of CFU-E, BFU-E and CFU-GM of human bone
marrow cells and induce a significant increase in the expression of TLR2, TLR3 and TLR4. This effect correlates with the activation of ERK1/2 and NF-kB
signaling cascades, but not AKT, as demonstrated by specific inhibition of these pathways. The activation of these two pathways by CSE induces the
release of TGF-b1 and IL-8, and these cytokines may regulate the expression of Toll receptors. Our hypothesis is that these cytokines and TLR
signaling pathways are tightly integrated.
doi:10.1371/journal.pone.0021173.g008
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concentration in each experiment.
Colony-forming Assay
Methylcellulose colony-forming assays were performed in
MethoCult H4434 complete medium with cytokines (StemCell
Technologies). In brief, Bone marrow mononuclear cells (BMCs)
exposure to 5% CSE, 10% CSE or control for 24 h, then were
seeded into complete methylcellulose media, the mixture is placed
in 35-mm culture dishes (1610
5 cells/each dish) and incubated at
37uC in 5% CO2 for approximately 7–14 days. After incubation,
colonies of CFU-E, BFU-E and CFU-GM were indentified and
counted using an inverted light microscope. All of the cultures
were done in duplicate.
Enzyme-linked Immunosorbent Assay (ELISA)
BMCs (1610
6 cells/ml) were incubated with control medium,
5% CSE, 10% CSE or 1 mg/ml of LPS for 24 h. Supernatants
were collected and analyzed for the presence of IL-8, IL-10, TNF-
a, TGF-b1, and VEGF by ELISA following the manufacturer’s
instructions. IL-10, TNF-a and TGF-b1 ELISA kit from
eBiosciences, IL-8 ELISA kit from BD Biosciences, and VEGF
ELISA kit from R&D Systems.
Flow Cytometry
BMCs were pretreated with PD98059 (10 mM), BAY11-7085
(5 mM), or Wortmannin (100 nM) for 60 min, and subsequently
were exposed to 10% CSE for 24 h. To detect cell surface
expression of TLR2, TLR3 and TLR4, the cells were incubated
with anti-TLR2-PE, anti-TLR3-PE or anti-TLR4-APC antibodies
(ebioscience) for 30 min in the dark on ice, washed and
resuspended in PBS. For intracellular TLR2, TLR3 and TLR4
staining, cells were fixed and permeabilized in Cytofix/Cytoperm
buffer (BD Bioscience) for 30 min at 4uC before staining for
TLR2, TLR3 and TLR4. Flow cytometry was performed using
the LSRII (BD Pharmingen), and the results were analyzed using
Flowjo 6.3.4 software (TreeStar).
Nuclear and Cytoplasmic Extracts and Western blot
To study the expression and nuclear translocation of NF-kB,
BMCs were incubated with control medium, 5% CSE, 10% CSE,
20% CSE or 1 mg/ml of LPS for 24 h, and then cells were
harvested. Nuclear and cytoplasmic protein fractions were
extracted using the NE-PER Nuclear and Cytoplasmic Extraction
Reagent Kit (Pierce) according to the manufacturer’s protocol.
The protein concentrations of both nuclear and cytoplasmic
extracts were measured by the Bio-Rad protein assay. 30 mgo f
each cytoplasmic and nuclear extract sample was analyzed by 10%
SDS-PAGE and Western blotted using specific antibodies diluted
1:1000 (NF-kB p65, PARP) or 1:5000 (b-actin). Anti-mouse HRP
or anti-rabbit HRP diluted 1:2000 was used as the secondary
antibody, and detected using an ECL detection system (Amersham
Biosciences).
Western Blot Analysis
BMCs were incubated with control medium, 5% CSE or 10%
CSE for 6 h. Cell lysates were prepared, and 30–50 mg of protein
was separated on 10% SDS-PAGE and subjected to immuno-
blotting with antibodies specific for phospho-AKT (Ser-473),
phospho-ERK1/2 (Thr202/Tyr204), phosphor-IkBa (Ser32),
total AKT, total ERK, and b-actin. In some instances, blots were
stripped in stripping buffer (Pierce) at 37uC for 15 min.
Statistical Analysis
Results are expressed as means 6 standard error, Kruskal-
Wallis One-way ANOVA and S-N-K were used to examine the
significance of the data, and p values ,0.05 were considered to be
statistically significant.
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